Thermo Fisher Scientific Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 01:55PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

All right, guys. Good morning. Thanks for joining us. My name is Tejas Savant, and I'm the Life Science Tools and Diagnostics analyst at Morgan Stanley. It's my pleasure to host Marc Casper, CEO of Thermo, so Marc, thank you so much for joining us this morning.

Marc N. Casper - Thermo Fisher Scientific Inc. - Chairman, President & CEO

Pleasure to be here.

Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

Before we get started, just a quick disclaimer I have to read off. For important disclosures, please see the Morgan Stanley research disclosures website at morganstanley.com/researchdisclosures. If you have any questions, please do reach out to your sales rep.

Questions and Answers:

Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

So with that, Marc, we'll kick it off. Maybe just to set the stage, can you just talk about your -- what you're most
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot